Consensus statement on perioperative use of neuromuscular monitoring

Anesthesia and Analgesia

Volumn 127, Issue 1, 2018, Pages 71-80

  Naguib, Mohamed ⁱ   Brull, Sorin J ^a   Kopman, Aaron F ^b   Hunter, Jennifer M ^c   Fülesdi, Béla ^d   Arkes, Hal R ^e   Elstein, Arthur ^f   Todd, Michael M ^g   Johnson, Ken B ^a,h  

^a MAYO CLINIC   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d UNIVERSITY OF DEBRECEN   (Hungary)

^e OHIO STATE UNIVERSITY   (United States)

^f UNIVERSITY OF ILLINOIS   (United States)

^g UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROMUSCULAR BLOCKING AGENT;

ACCELEROMYOGRAPHY; ARTICLE; CONSENSUS; ELECTROMYOGRAPHY; HAND MUSCLE; HUMAN; KINEMYOGRAPHY; MECHANOMYOGRAPHY; MEDICAL DOCUMENTATION; MEDICAL EDUCATION; MOTOR EVOKED POTENTIAL; MUSCLE CONTRACTION; MYOGRAPHY; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR FUNCTION; NEUROMUSCULAR MONITORING; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; TOTAL QUALITY MANAGEMENT; ANESTHESIOLOGY; ANESTHETIC RECOVERY; DEVICES; DRUG EFFECT; ELECTROSTIMULATION; HAND; INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING; NEUROMUSCULAR JUNCTION; PATIENT SAFETY; PRACTICE GUIDELINE; RISK FACTOR; STANDARDS;

ANESTHESIA RECOVERY PERIOD; ANESTHESIOLOGY; CONSENSUS; ELECTRIC STIMULATION; HAND; HUMANS; INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR JUNCTION; PATIENT SAFETY; PERIOPERATIVE CARE; RISK FACTORS;

EID: 85050117219     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000002670     Document Type: Article

References (85)

1. Heier T, Caldwell JE, Feiner JR, Liu L, Ward T, Wright PM. Relationship between normalized adductor pollicis train-of-four ratio and manifestations of residual neuromuscular block: a study using acceleromyography during near steady-state concentrations of mivacurium. Anesthesiology. 2010;113:825-832.
2. Eriksson LI, Sundman E, Olsson R, et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology. 1997;87:1035-1043.
3. Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology. 2000;92:977-984.
4. Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology. 1997;86:765-771.
5. Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg. 2010;111:110-119.
6. Videira RL, Vieira JE. What rules of thumb do clinicians use to decide whether to antagonize nondepolarizing neuromuscular blocking drugs? Anesth Analg. 2011;113:1192-1196.
7. Kotake Y, Ochiai R, Suzuki T, et al. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg. 2013;117:345-351.
8. Phillips S, Stewart PA, Bilgin AB. A survey of the management of neuromuscular blockade monitoring in Australia and New Zealand. Anaesth Intensive Care. 2013;41:374-379.
9. Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth. 2007;98:302-316.
10. Fortier LP, McKeen D, Turner K, et al. The RECITE Study: a Canadian prospective, multicenter study of the incidence and severity of residual neuromuscular blockade. Anesth Analg. 2015;121:366-372.
11. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107:130-137.
12. Kumar GV, Nair AP, Murthy HS, Jalaja KR, Ramachandra K, Parameshwara G. Residual neuromuscular blockade affects postoperative pulmonary function. Anesthesiology. 2012;117:1234-1244.
13. Arbous MS, Meursing AE, van Kleef JW, et al. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology. 2005;102:257-268.
14. Bulka CM, Terekhov MA, Martin BJ, Dmochowski RR, Hayes RM, Ehrenfeld JM. Nondepolarizing neuromuscular blocking agents, reversal, and risk of postoperative pneumonia. Anesthesiology. 2016;125:647-655.
15. Bronsert MR, Henderson WG, Monk TG, et al. Intermediate-acting nondepolarizing neuromuscular blocking agents and risk of postoperative 30-day morbidity and mortality, and long-term survival. Anesth Analg. 2017;124:1476-1483.
16. Viby-Mogensen J, Jensen NH, Engbaek J, Ording H, Skovgaard LT, Chraemmer-Jørgensen B. Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology. 1985;63:440-443.
17. Pedersen T, Viby-Mogensen J, Bang U, Olsen NV, Jensen E, Engboek J. Does perioperative tactile evaluation of the train-of-four response influence the frequency of postoperative residual neuromuscular blockade? Anesthesiology. 1990;73:835-839.
18. Beemer GH, Rozental P. Postoperative neuromuscular function. Anaesth Intensive Care. 1986;14:41-45.
19. Cammu G, De Witte J, De Veylder J, et al. Postoperative residual paralysis in outpatients versus inpatients. Anesth Analg. 2006;102:426-429.
20. Todd MM, Hindman BJ, King BJ. The implementation of quantitative electromyographic neuromuscular monitoring in an academic anesthesia department. Anesth Analg. 2014;119:323-331.
21. Brull SJ, Kopman AF. Current status of neuromuscular reversal and monitoring: challenges and opportunities. Anesthesiology. 2017;126:173-190.
22. Naguib M, Johnson KB. Innovative disruption in the world of neuromuscular blockade: what is the “state of the art?” Anesthesiology. 2017;126:12-15.
23. Nemes R, Fülesdi B, Pongrácz A, et al. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: a partially randomised placebo controlled trial. Eur J Anaesthesiol. 2017;34:609-616.
24. Green LW, Ottoson JM, García C, Hiatt RA. Diffusion theory and knowledge dissemination, utilization, and integration in public health. Annu Rev Public Health. 2009;30:151-174.
25. Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011;104:510-520.
26. Rocuronium Package Insert. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/078717s000lbl.pdf, Accessed May 11, 2016.
27. Schultz P, Ibsen M, Østergaard D, Skovgaard LT. Onset and duration of action of rocuronium-from tracheal intubation, through intense block to complete recovery. Acta Anaesthesiol Scand. 2001;45:612-617.
28. Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003;98:1042-1048.
29. Baillard C, Clec'h C, Catineau J, et al. Postoperative residual neuromuscular block: a survey of management. Br J Anaesth. 2005;95:622-626.
30. Todd MM, Hindman BJ. The implementation of quantitative electromyographic neuromuscular monitoring in an academic anesthesia department: follow-up observations. Anesth Analg. 2015;121:836-838.
31. Della Rocca G, Iannuccelli F, Pompei L, Pietropaoli P, Reale C, Di Marco P. Neuromuscular block in Italy: a survey of current management. Minerva Anestesiol. 2012;78:767-773.
32. Brull SJ, Naguib M, Miller RD. Residual neuromuscular block: rediscovering the obvious. Anesth Analg. 2008;107:11-14.
33. Donati F. Neuromuscular monitoring: what evidence do we need to be convinced? Anesth Analg. 2010;111:6-8.
34. Kopman AF. Managing neuromuscular block: where are the guidelines? Anesth Analg. 2010;111:9-10.
35. Brull SJ, Naguib M. What we know: precise measurement leads to patient comfort and safety. Anesthesiology. 2011;115:918-920.
36. Hudson RJ. Neuromuscular monitoring should be required when neuromuscular blocking drugs are used: is it time to change the Canadian guidelines? Can J Anaesth. 2016;63:891.
37. Lundstrøm LH, Duez CH, Nørskov AK, et al. Avoidance versus use of neuromuscular blocking agents for improving conditions during tracheal intubation or direct laryngoscopy in adults and adolescents. Cochrane Database Syst Rev. 2017;5:CD009237.
38. Miskovic A, Lumb AB. Postoperative pulmonary complications. Br J Anaesth. 2017;118:317-334.
39. Fleisher LA, Linde-Zwirble WT. Incidence, outcome, and attributable resource use associated with pulmonary and cardiac complications after major small and large bowel procedures. Perioper Med (Lond). 2014;3:7.
40. Kopman AF, Naguib M. Laparoscopic surgery and muscle relaxants: is deep block helpful? Anesth Analg. 2015;120:51-58.
41. Naguib M, Brull SJ, Johnson KB. Conceptual and technical insights into the basis of neuromuscular monitoring. Anaesthesia. 2017;72(suppl 1):16-37.
42. Ali HH, Utting JE, Gray C. Stimulus frequency in the detection of neuromuscular block in humans. Br J Anaesth. 1970;42:967-978.
43. Ali HH, Utting JE, Gray TC. Quantitative assessment of residual antidepolarizing block. I. Br J Anaesth. 1971;43:473-477.
44. Ali HH, Utting JE, Gray TC. Quantitative assessment of residual antidepolarizing block. II. Br J Anaesth. 1971;43:478-485.
45. Viby-Mogensen J, Howardy-Hansen P, Chraemmer-Jørgensen B, Ording H, Engbaek J, Nielsen A. Posttetanic count (PTC): a new method of evaluating an intense nondepolarizing neuromuscular blockade. Anesthesiology. 1981;55:458-461.
46. Merton PA. Voluntary strength and fatigue. J Physiol. 1954;123:553-564.
47. Stanec A, Heyduk J, Stanec G, Orkin LR. Tetanic fade and post-tetanic tension in the absence of neuromuscular blocking agents in anesthetized man. Anesth Analg. 1978;57:102-107.
48. Kopman AF, Epstein RH, Flashburg MH. Use of 100-Hertz tetanus as an index of recovery from pancuronium-induced non-depolarizing neuromuscular blockade. Anesth Analg. 1982;61:439-441.
49. Brull SJ, Silverman DG. Tetanus-induced changes in apparent recovery after bolus doses of atracurium or vecuronium. Anesthesiology. 1992;77:642-645.
50. Dupuis JY, Martin R, Tessonnier JM, Tétrault JP. Clinical assessment of the muscular response to tetanic nerve stimulation. Can J Anaesth. 1990;37:397-400.
51. Werba A, Klezl M, Schramm W, et al. The level of neuromuscular block needed to suppress diaphragmatic movement during tracheal suction in patients with raised intracranial pressure: a study with vecuronium and atracurium. Anaesthesia. 1993;48:301-303.
52. Fernando PU, Viby-Mogensen J, Bonsu AK, Tamilarasan A, Muchhal KK, Lambourne A. Relationship between posttetanic count and response to carinal stimulation during vecuronium-induced neuromuscular blockade. Acta Anaesthesiol Scand. 1987;31:593-596.
53. Brull SJ, Silverman DG. Pulse width, stimulus intensity, electrode placement, and polarity during assessment of neuromuscular block. Anesthesiology. 1995;83:702-709.
54. Rosenberg H, Greenhow DE. Peripheral nerve stimulator performance: the influence of output polarity and electrode placement. Can Anaesth Soc J. 1978;25:424-426.
55. Caffrey RR, Warren ML, Becker KE Jr. Neuromuscular blockade monitoring comparing the orbicularis oculi and adductor pollicis muscles. Anesthesiology. 1986;65:95-97.
56. Donati F, Meistelman C, Plaud B. Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi, and adductor pollicis muscles. Anesthesiology. 1990;73:870-875.
57. Thilen SR, Hansen BE, Ramaiah R, Kent CD, Treggiari MM, Bhananker SM. Intraoperative neuromuscular monitoring site and residual paralysis. Anesthesiology. 2012;117:964-972.
58. Donati F. Neuromuscular monitoring: more than meets the eye. Anesthesiology. 2012;117:934-936.
59. Ali HH, Savarese JJ, Lebowitz PW, Ramsey FM. Twitch, tetanus and train-of-four as indices of recovery from nondepolarizing neuromuscular blockade. Anesthesiology. 1981;54:294-297.
60. Katz RL. Comparison of electrical and mechanical recording of spontaneous and evoked muscle activity. The clinical value of continuous recording as an aid to the rational use of muscle relaxants during anesthesia. Anesthesiology. 1965;26:204-211.
61. Engbaek J. Monitoring of neuromuscular transmission by electromyography during anaesthesia. A comparison with mechanomyography in cat and man. Dan Med Bull. 1996;43:301-316.
62. Kopman AF. The dose-effect relationship of metocurine: the integrated electromyogram of the first dorsal interosseous muscle and the mechanomyogram of the adductor pollicis compared. Anesthesiology. 1988;68:604-607.
63. Engbaek J, Skovgaard LT, Friis B, Kann T, Viby-Mogensen J. Monitoring of the neuromuscular transmission by electromyography (I). Stability and temperature dependence of evoked EMG response compared to mechanical twitch recordings in the cat. Acta Anaesthesiol Scand. 1992;36:495-504.
64. Kopman AF, Justo MD, Mallhi MU, Abara CE, Neuman GG. The influence of changes in hand temperature on the indirectly evoked electromyogram of the first dorsal interosseous muscle. Can J Anaesth. 1995;42:1090-1095.
65. Viby-Mogensen J, Jensen E, Werner M, Nielsen HK. Measurement of acceleration: a new method of monitoring neuromuscular function. Acta Anaesthesiol Scand. 1988;32:45-48.
66. Jensen E, Viby-Mogensen J, Bang U. The accelograph: a new neuromuscular transmission monitor. Acta Anaesthesiol Scand. 1988;32:49-52.
67. Suzuki T, Fukano N, Kitajima O, Saeki S, Ogawa S. Normalization of acceleromyographic train-of-four ratio by baseline value for detecting residual neuromuscular block. Br J Anaesth. 2006;96:44-47.
68. Kern SE, Johnson JO, Westenskow DR, Orr JA. An effectiveness study of a new piezoelectric sensor for train-of-four measurement. Anesth Analg. 1994;78:978-982.
69. Motamed C, Kirov K, Combes X, Duvaldestin P. Comparison between the Datex-Ohmeda M-NMT module and a force-displacement transducer for monitoring neuromuscular blockade. Eur J Anaesthesiol. 2003;20:467-469.
70. Söderström CM, Eskildsen KZ, Gätke MR, Staehr-Rye AK. Objective neuromuscular monitoring of neuromuscular blockade in Denmark: an online-based survey of current practice. Acta Anaesthesiol Scand. 2017;61:619-626.
71. Indications of neuromuscular blockade in anaesthesia. Short text. Ann Fr Anesth Reanim. 2000;19(suppl 2):352s-355s.
72. Checketts MR, Alladi R, Ferguson K, et al; Association of Anaesthetists of Great Britain and Ireland. Recommendations for standards of monitoring during anaesthesia and recovery 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia. 2016;71:85-93.
73. American Society of Anesthesiologists' Standards and Practice Parameters Committee. Standards for Basic Anesthetic Monitoring. Available at: http://www.asahq.org/search#q=STANDARDS%20FOR%20BASIC%20ANESTHETIC2 0MONITORING&sort=relevancy. Accessed November 21, 2017.
74. Engbaek J, Ostergaard D, Viby-Mogensen J. Double burst stimulation (DBS): a new pattern of nerve stimulation to identify residual neuromuscular block. Br J Anaesth. 1989;62:274-278.
75. Gupta DM, Boland RJ Jr, Aron DC. The physician's experience of changing clinical practice: a struggle to unlearn. Implement Sci. 2017;12:28.
76. Prasad V, Ioannidis JP. Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices. Implement Sci. 2014;9:1.
77. McGill N, Yoon M. A quality improvement program involving protocolised reversal from neuromuscular block. Anaesthesia. 2017;72:1152-1153.
78. Eichhorn JH, Cooper JB, Cullen DJ, Maier WR, Philip JH, Seeman RG. Standards for patient monitoring during anesthesia at Harvard Medical School. JAMA. 1986;256:1017-1020.
79. Butterly A, Bittner EA, George E, Sandberg WS, Eikermann M, Schmidt U. Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge. Br J Anaesth. 2010;105:304-309.
80. Berg H, Roed J, Viby-Mogensen J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand. 1997;41:1095-1103.
81. Grol R, Dalhuijsen J, Thomas S, Veld C, Rutten G, Mokkink H. Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. BMJ. 1998;317:858-861.
82. National Institute for Health Research. Getting evidence into practice. NIHR Centre for Reviews and Dissemination Effective Health Care Bulletin. 1999;5:1-16.
83. Chaillet N, Dubé E, Dugas M, et al. Evidence-based strategies for implementing guidelines in obstetrics: a systematic review. Obstet Gynecol. 2006;108:1234-1245.
84. Wyszewianski L, Green LA. Strategies for changing clinicians' practice patterns. A new perspective. J Fam Pract. 2000;49:461-464.
85. Gurses AP, Marsteller JA, Ozok AA, Xiao Y, Owens S, Pronovost PJ. Using an interdisciplinary approach to identify factors that affect clinicians' compliance with evidence-based guidelines. Crit Care Med. 2010;38:S282-S291.